Vir Biotechnology schedules Q1 2026 earnings call for 4:30 p.m. ET

Vir Biotechnology schedules Q1 2026 earnings call for 4:30 p.m. ET
Vir Biotechnology Q1 2026 earnings call

Vir Biotechnology has announced it will deliver a corporate update and release its first-quarter 2026 financial results during an investor conference call at 4:30 p.m. ET and 1:30 p.m. PT.

The company invites investors and stakeholders to join the event to gain insight into its quarterly performance and strategic outlook. Additional details and the webcast link are available on Vir Biotechnology's investor relations website.

Vir Biotechnology previously scheduled its first-quarter 2026 earnings release and investor call for May 6, according to a company announcement (details). CEO Marianne De Backer also recently joined a live fireside chat at the Bank of America Securities 2026 Healthcare Conference (event summary). These events follow the company’s ongoing communications with investors.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.